trending Market Intelligence /marketintelligence/en/news-insights/trending/8a_ujqm-wuohaj6v4hh7qg2 content esgSubNav
In This List

Calyxt appoints CEO

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Calyxt appoints CEO

Calyxt Inc. appointed James Blome CEO with effect from Oct. 1.

The Minnesota-based gene-editing agriculture company is a unit of Paris-based biotech company Cellectis S.A.

Calyxt's former CEO Yves Ribeill remains a board member.

Blome was the CEO and president of Bayer Crop Science and has more than 25 years of experience in the agriculture industry. He also held executive positions at Agriliance LLC prior to Bayer.